Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl E Mogensen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Diabetes Care|March 1, 2006
Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE studyHans Ibsen, Michael H Olsen, Kristian Wachtell, et al.
Clinical Science (London, England : 1979)|March 4, 2006
Effects of blood pressure lowering and metabolic control on systolic left ventricular function in Type II diabetes mellitusNiels H Andersen, Steen H Poulsen, Per L Poulsen, et al.
Kidney International|May 3, 2014
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global OutcomesMark E Molitch, Amanda I Adler, Allan Flyvbjerg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 29, 2013
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trialJuan C Arjona Ferreira, Dalila Corry, Carl E Mogensen, et al.
Journal of Hypertension|March 5, 2002
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE studyKristian Wachtell, Michael H Olsen, Björn Dahlöf, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2012
Prediction of kidney-related outcomes in patients with type 2 diabetesMeg J Jardine, Jun Hata, Mark Woodward, et al.
American Heart Journal|February 9, 2002
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint ReductionKristian Wachtell, Vittorio Palmieri, Michael H Olsen, et al.
The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Diabetes Care|March 1, 2006
Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE studyHans Ibsen, Michael H Olsen, Kristian Wachtell, et al.
Clinical Science (London, England : 1979)|March 4, 2006
Effects of blood pressure lowering and metabolic control on systolic left ventricular function in Type II diabetes mellitusNiels H Andersen, Steen H Poulsen, Per L Poulsen, et al.
Kidney International|May 3, 2014
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global OutcomesMark E Molitch, Amanda I Adler, Allan Flyvbjerg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 29, 2013
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trialJuan C Arjona Ferreira, Dalila Corry, Carl E Mogensen, et al.
Journal of Hypertension|March 5, 2002
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE studyKristian Wachtell, Michael H Olsen, Björn Dahlöf, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2012
Prediction of kidney-related outcomes in patients with type 2 diabetesMeg J Jardine, Jun Hata, Mark Woodward, et al.
American Heart Journal|February 9, 2002
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint ReductionKristian Wachtell, Vittorio Palmieri, Michael H Olsen, et al.
The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.
Pageof 2